PORTLAND, Ore., April 30, 2014 (GLOBE NEWSWIRE) -- Galena Biopharma (Nasdaq: GALE ), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, today announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer will present a corporate update at the 39th Annual Deutsche Bank Health Care Conference. The presentation will take place on Wednesday, May 7, 2014 at 10:40 a.m. ET at The InterContinental Hotel in Boston, MA.
The presentation will be webcast and available on the Investors section of the Company's website at www.galenabiopharma.com .
About Galena Biopharma
Galena Biopharma, Inc. (Nasdaq: GALE ) is a Portland, Oregon-based biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care. For more information please visit: www.galenabiopharma.com .
Remy Bernarda Vice President, Marketing & Communications (503) 405-8258